<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN
        </div>
        <div class="card-body">
                <p>NUP98-HOXA9, the chimeric protein resulting from the t(7;11)(p15;p15) chromosomal translocation, is a prototype of several NUP98 fusions that occur in myelodysplastic syndromes and acute myeloid leukemia. We examined its effect on differentiation, proliferation, and gene expression in primary human CD34+ hematopoietic cells. Colony-forming cell (CFC) assays in semisolid medium combined with morphologic examination and flow cytometric immunophenotyping revealed that NUP98-HOXA9 increased the numbers of erythroid precursors and impaired both myeloid and erythroid differentiation. In continuous liquid culture, cells transduced with NUP98-HOXA9 exhibited a biphasic growth curve with initial growth inhibition followed by enhanced long-term proliferation, suggesting an increase in the numbers of primitive self-renewing cells. This was confirmed by a dramatic increase in the numbers of long-term culture-initiating cells, the most primitive hematopoietic cells detectable in vitro. To understand the molecular mechanisms underlying the effects of NUP98-HOXA9 on hematopoietic cell proliferation and differentiation, oligonucleotide microarray analysis was done at several time points over 16 days, starting at 6 hours posttransduction. The early growth suppression was preceded by up-regulation of IFNbeta1 and accompanied by marked up-regulation of IFN-induced genes, peaking at 3 days posttransduction. In contrast, oncogenes such as homeobox transcription factors, FLT3, KIT, and WT1 peaked at 8 days or beyond, coinciding with increased proliferation. In addition, several putative tumor suppressors and genes associated with hematopoietic differentiation were repressed at later time points. These findings provide a comprehensive picture of the changes in proliferation, differentiation, and global gene expression that underlie the leukemic transformation of human hematopoietic cells by NUP98-HOXA9.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M3210">M3210</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:240">ncbigene:240</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:80832">ncbigene:80832</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:54602">ncbigene:54602</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7045">ncbigene:7045</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3082">ncbigene:3082</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5008">ncbigene:5008</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:56154">ncbigene:56154</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3976">ncbigene:3976</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9420">ncbigene:9420</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:953">ncbigene:953</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2752">ncbigene:2752</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6374">ncbigene:6374</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10394">ncbigene:10394</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6279">ncbigene:6279</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9771">ncbigene:9771</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3046">ncbigene:3046</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:222487">ncbigene:222487</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10462">ncbigene:10462</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3575">ncbigene:3575</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2213">ncbigene:2213</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:57205">ncbigene:57205</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9332">ncbigene:9332</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2113">ncbigene:2113</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:213">ncbigene:213</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5473">ncbigene:5473</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6280">ncbigene:6280</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9935">ncbigene:9935</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2212">ncbigene:2212</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6354">ncbigene:6354</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8611">ncbigene:8611</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M3210&#39;, name=&#39;TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN&#39;), definition=&#39;NUP98-HOXA9, the chimeric protein resulting from the t(7;11)(p15;p15) chromosomal translocation, is a prototype of several NUP98 fusions that occur in myelodysplastic syndromes and acute myeloid leukemia. We examined its effect on differentiation, proliferation, and gene expression in primary human CD34+ hematopoietic cells. Colony-forming cell (CFC) assays in semisolid medium combined with morphologic examination and flow cytometric immunophenotyping revealed that NUP98-HOXA9 increased the numbers of erythroid precursors and impaired both myeloid and erythroid differentiation. In continuous liquid culture, cells transduced with NUP98-HOXA9 exhibited a biphasic growth curve with initial growth inhibition followed by enhanced long-term proliferation, suggesting an increase in the numbers of primitive self-renewing cells. This was confirmed by a dramatic increase in the numbers of long-term culture-initiating cells, the most primitive hematopoietic cells detectable in vitro. To understand the molecular mechanisms underlying the effects of NUP98-HOXA9 on hematopoietic cell proliferation and differentiation, oligonucleotide microarray analysis was done at several time points over 16 days, starting at 6 hours posttransduction. The early growth suppression was preceded by up-regulation of IFNbeta1 and accompanied by marked up-regulation of IFN-induced genes, peaking at 3 days posttransduction. In contrast, oncogenes such as homeobox transcription factors, FLT3, KIT, and WT1 peaked at 8 days or beyond, coinciding with increased proliferation. In addition, several putative tumor suppressors and genes associated with hematopoietic differentiation were repressed at later time points. These findings provide a comprehensive picture of the changes in proliferation, differentiation, and global gene expression that underlie the leukemic transformation of human hematopoietic cells by NUP98-HOXA9.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;16818636&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;240&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;80832&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;54602&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7045&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3082&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5008&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;56154&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3976&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9420&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;953&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2752&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6374&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10394&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6279&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9771&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3046&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;222487&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10462&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3575&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2213&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;57205&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9332&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2113&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;213&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5473&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6280&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9935&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2212&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6354&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8611&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 2S&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>